Literature DB >> 2088984

Utilization of anti-acinar cell monoclonal antibodies in the purification of rat and canine islets.

P Soon-Shiong1, R Heintz, T Fujioka, P Terasaki, N Merideth, R P Lanza.   

Abstract

We have developed two immunological methods of islet purification using anti-acinar cell monoclonal antibodies (McAb). Pancreatic digestion with collagenase followed by depletion of acinar cells with McAb and complement or magnetic immunomicrospheres (MIMS) yields large numbers of intact islets. We compared the islets thus obtained with either handpicked (HP) islets, or islets separated on density gradients alone, for yield, purity, in vitro in sulin secretory capacities, and in vivo functional viability. Exposure of canine acinar tissue to the cytotoxic McAb resulted in a seven-fold enrichment in islet concentration, with preparations of 65% to 87% purity. Islet yield, however, was impaired by the procedure of McAb treatment, reducing the average yield from the control digestate of 40,000 to 60,000 islets/pancreas by 40% to 45%. Using the MIMS method in the rat model, the islet yield was 73% that obtained by the HP method (378 +/- 8 vs 519 +/- 31 per pancreas). The purity of the MIMS isolated islets was 84 +/- 1.9%, ranging from 75% to 95%. Analysis of the complement and MIMS treatments by in vitro static glucose tests and the capacity to restore normoglycemia after isografting in streptozotocin-induced diabetic rats indicates that the functional integrity of the islets was not affected by the purification process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088984

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  1 in total

1.  Excellent Islet Yields after 18-h Porcine Pancreas Preservation by Ductal Injection, Pancreas Preservation with MK Solution, Bottle Purification, and Islet Purification Using Iodixanol with UW Solution and Iodixanol with MK Solution.

Authors:  Kazuho Kuwae; Chika Miyagi-Shiohira; Eri Hamada; Yoshihito Tamaki; Kai Nishime; Mayuko Sakai; Tasuku Yonaha; Erika Makishi; Issei Saitoh; Masami Watanabe; Hirofumi Noguchi
Journal:  J Clin Med       Date:  2019-09-30       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.